HUMAN GENOME SCIENCES INC Stock-Based Compensation
HUMAN GENOME SCIENCES INC reported Stock-Based Compensation of $10.47 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $10.47M, a 24.16% increase year-over-year.
- HUMAN GENOME SCIENCES INC share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $10.79M, a 63.19% increase year-over-year.
- HUMAN GENOME SCIENCES INC share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $13.91M, a 82.44% increase year-over-year.
- HUMAN GENOME SCIENCES INC share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $6.95M, a 0.49% decline year-over-year.
- HUMAN GENOME SCIENCES INC share-based payment arrangement, noncash expense for fiscal 2011 was $35.91M, a 41.23% increase from fiscal 2010.
- HUMAN GENOME SCIENCES INC share-based payment arrangement, noncash expense for fiscal 2010 was $25.43M, a 103.05% increase from fiscal 2009.
- HUMAN GENOME SCIENCES INC share-based payment arrangement, noncash expense for fiscal 2009 was $12.52M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2012-06-30 | $10.47M 10-Q · filed 2012-07-26 | $21.36M 10-Q · filed 2012-07-26 | $35.18M derived: sum of 3 quarters · filed 2012-07-26 | $42.13M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $10.79M 10-Q · filed 2012-04-26 | $24.70M derived: sum of 2 quarters · filed 2012-04-26 | $31.66M derived: sum of 3 quarters · filed 2012-04-26 | $40.09M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $13.91M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $20.86M derived: sum of 2 quarters · filed 2012-02-28 | $29.30M derived: sum of 3 quarters · filed 2012-07-26 | $35.91M 10-K · filed 2012-02-28 |
| 2011-09-30 | $6.95M 10-Q · filed 2011-10-28 | $15.39M derived: sum of 2 quarters · filed 2012-07-26 | $22.00M 10-Q · filed 2011-10-28 | $29.63M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $8.44M 10-Q · filed 2012-07-26 | $15.05M 10-Q · filed 2012-07-26 | $22.68M derived: sum of 3 quarters · filed 2012-07-26 | $29.66M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $6.61M 10-Q · filed 2012-04-26 | $14.24M derived: sum of 2 quarters · filed 2012-04-26 | $21.22M derived: sum of 3 quarters · filed 2012-04-26 | $28.20M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $7.63M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $14.61M derived: sum of 2 quarters · filed 2012-02-28 | $21.59M derived: sum of 3 quarters · filed 2012-02-28 | $25.43M 10-K · filed 2012-02-28 |
| 2010-09-30 | $6.98M 10-Q · filed 2011-10-28 | $13.96M derived: sum of 2 quarters · filed 2011-10-28 | $17.80M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $6.97M 10-Q · filed 2011-07-28 | $10.82M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $3.84M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $12.52M 10-K · filed 2012-02-28 |